Ads
related to: inhaled drugs for pulmonary hypertension medications to avoid constipationdiscoverpanel.com has been visited by 10K+ users in the past month
assistantfish.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation, is a vasodilator that is used for the treatment of pulmonary arterial hypertension. [6] Treprostinil was approved for use in the United States in May 2002. [7]
Iloprost, sold under the brand name Ventavis among others, is a medication used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon, frostbite, and other conditions in which the blood vessels are constricted and blood cannot flow to the tissues. [4] Iloprost is a prostacyclin mimetic. [1]
Inhaled ipratropium does not decrease mucociliary clearance. [21] The inhalation itself can cause headache and irritation of the throat in a few percent of patients. [20] Urinary retention has been reported in patients receiving doses by nebulizer. As a result, caution may be warranted, especially by men with prostatic hypertrophy. [23]
Pulmonary drug delivery is a route of administration in which patients use an inhaler to inhale their medications and drugs are absorbed into the bloodstream via the lung mucous membrane. This technique is most commonly used in the treatment of lung diseases, for example, asthma and chronic obstructive pulmonary disease (COPD) .
(Reuters) -The U.S. Food and Drug Administration on Monday delayed traditional approval for Liquidia Corp's inhaled drug for types of lung disorders, and allowed only tentative clearances, sending ...
Tiotropium is used as maintenance treatment of chronic obstructive pulmonary disease (COPD). [16] [17] It may also be used as an add-on therapy in people with moderate-to-severe asthma on medium to high dose inhaled corticosteroids (ICS). [18] [19] It is not however approved for acute exacerbations of COPD or acute worsening of asthma. [10]
Soluble guanylate cyclase (sGC) stimulators are a class of drugs developed to treat heart failure, pulmonary hypertension, and other diseases. The first-in-class medication was riociguat, approved in 2013 for pulmonary hypertension. [1] [2] They have also been investigated for hypertension, systemic sclerosis, and sickle cell disease. [3] [1]
6 Pulmonary surfactants. 7 Sympathomimetic amines. 8 Miscellaneous. 9 Historical. Toggle Historical subsection. ... Inhalant – non-medical drugs administered via ...
Ads
related to: inhaled drugs for pulmonary hypertension medications to avoid constipationdiscoverpanel.com has been visited by 10K+ users in the past month
assistantfish.com has been visited by 10K+ users in the past month